Kyle Faget Discusses Regulating Software as a Medical Device on MedTech Connect Podcast
January 6, 2023
Medtech Insight
Foley & Lardner LLP Partner Kyle Faget is interviewed in the first episode of MedTech Connect, a new digital health podcast series by Medtech Insight, about the complexities behind regulating software as a medical device (SaMD).
In the episode, “How Do We Regulate Software as a Medical Device?” Faget offers valuable insight on the regulatory landscape of SaMD, and provides clarity for businesses that might be unsure if their software is even regulated by the U.S. Food and Drug Administration, let alone understand how to go about the clearance process.
Listen to the episode on Apple Podcasts, SoundCloud, and Spotify.
(Subscription required)
People
Related News
April 3, 2026
In the News
David Rosen Weighs in on FDA's Pharma PR Crackdown – 'Stick to the Data'
Foley & Lardner LLP partner David Rosen shared insights on the regulatory challenges pharmaceutical companies face when publicly communicating around new cancer therapies in the MM+M article, “When a podcast becomes promotion: Inside the FDA’s warning shot at ImmunityBio.”
April 2, 2026
In the News
Susan Poll Klaessy and Adrienne Walker Named Chair and Vice Chair of Foley’s Bankruptcy & Business Reorganizations Practice
Foley & Lardner LLP partner Susan Poll Klaessy was appointed chair of the firm’s global Bankruptcy & Business Reorganizations Practice Group. Partner Adrienne Walker will serve as vice chair, supporting the continued growth and strategic direction of the practice.
April 1, 2026
In the News
Foley Featured on Top 10 Sales of 2025 List by Golf Inc.
Foley & Lardner LLP advised on two transactions named among Golf Inc.’s Top 10 Sales of 2025.